Bafameritin-M
Bafameritin-M Brand names, Bafameritin-M Analogs
Bafameritin-M Brand Names Mixture
- No information avaliable
Bafameritin-M Chemical_Formula
C15H15NO2
Bafameritin-M RX_link
http://www.rxlist.com/cgi/generic3/mefenamic.htm
Bafameritin-M fda sheet
Bafameritin-M msds (material safety sheet)
Bafameritin-M Synthesis Reference
No information avaliable
Bafameritin-M Molecular Weight
241.285 g/mol
Bafameritin-M Melting Point
230-231 oC
Bafameritin-M H2O Solubility
20 mg/L
Bafameritin-M State
Solid
Bafameritin-M LogP
4.041
Bafameritin-M Dosage Forms
Bolus; Capsule; Capsule (enteric-coated); Drops; Liquid; Lotion; Powder; Powder for solution; Shampoo; Soap bar; Solution; Stick; Syrup; Tablet; Tablet (extended-release)
Bafameritin-M Indication
For the treatment of rheumatoid arthritis, osteoarthritis, dysmenorrhea, and mild to moderate pain, inflammation, and fever.
Bafameritin-M Pharmacology
Mefenamic acid, an anthranilic acid derivative, is a member of the fenamate group of nonsteroidal anti-inflammatory drugs (NSAIDs). It exhibits anti-inflammatory, analgesic, and antipyretic activities. Similar to other NSAIDs, mefenamic acid inhibits prostaglandin synthetase.
Bafameritin-M Absorption
Mefenamic acid is rapidly absorbed after oral administration.
Bafameritin-M side effects and Toxicity
Oral, rat LD50: 740 mg/kg. Symptoms of overdose may include severe stomach pain, coffee ground-like vomit, dark stool, ringing in the ears, change in amount of urine, unusually fast or slow heartbeat, muscle weakness, slow or shallow breathing, confusion, severe headache or loss of consciousness.
Bafameritin-M Patient Information
Bafameritin-M Organisms Affected
Humans and other mammals
